Literature DB >> 27394132

Comparison of two different modes of molecular adsorbent recycling systems for liver dialysis.

Euan Soo1,2, Anja Sanders3, Karlheinz Heckert1, Tobias Vinke1, Franz Schaefer1, Claus Peter Schmitt4.   

Abstract

BACKGROUND: In children acute liver failure is a rare but life-threatening condition from which two-thirds do not recover with supportive therapy. Treatment is limited by the availability of liver transplants. Molecular adsorbent recirculating system (MARS) dialysis is a bridge to transplantation that enhances the chances of survival during the waiting period for a transplant, although it cannot improve survival. Open albumin dialysis (OPAL) is a new mode of albumin dialysis developed to further improve dialysis efficiency. CASE DIAGNOSIS/TREATMENT: We report a paediatric case of acute-on-chronic liver failure and compare the two modes of albumin dialysis, namely, the MARS and OPAL, used to treat this patient's cholestatic pruritus. Removal of total and direct bilirubin, ammonia and bile acids were measured by serial blood tests. There was an increased removal of bile acids with the OPAL mode, whereas the removal of total and direct bilirubin and ammonia was similar in both modes. The patient reported better improvement in pruritus following OPAL compared to dialysis with the MARS.
CONCLUSION: OPAL may offer a better solution than the MARS in the treatment of refractory pruritus in liver failure.

Entities:  

Keywords:  Albumin dialysis; Children; Cholestatic pruritus; MARS; OPAL

Mesh:

Substances:

Year:  2016        PMID: 27394132     DOI: 10.1007/s00467-016-3451-0

Source DB:  PubMed          Journal:  Pediatr Nephrol        ISSN: 0931-041X            Impact factor:   3.714


  15 in total

Review 1.  The role of molecular adsorbent recirculating system dialysis for extracorporeal liver support in children.

Authors:  Betti Schaefer; Claus Peter Schmitt
Journal:  Pediatr Nephrol       Date:  2012-11-22       Impact factor: 3.714

2.  Extracorporeal albumin dialysis with the molecular adsorbent recirculating system in acute-on-chronic liver failure: the RELIEF trial.

Authors:  Rafael Bañares; Frederik Nevens; Fin Stolze Larsen; Rajiv Jalan; Agustín Albillos; Matthias Dollinger; Faouzi Saliba; Tilman Sauerbruch; Sebastian Klammt; Johann Ockenga; Albert Pares; Julia Wendon; Tanja Brünnler; Ludwig Kramer; Philippe Mathurin; Manuel de la Mata; Antonio Gasbarrini; Beat Müllhaupt; Alexander Wilmer; Wim Laleman; Martin Eefsen; Sambit Sen; Alexander Zipprich; Teresa Tenorio; Marco Pavesi; Hartmut H-J Schmidt; Steffen Mitzner; Roger Williams; Vicente Arroyo
Journal:  Hepatology       Date:  2013-02-15       Impact factor: 17.425

3.  Molecular adsorbent recirculating system as artificial support therapy for liver failure: a meta-analysis.

Authors:  Arjun Vaid; Haval Chweich; Ethan M Balk; Bertrand L Jaber
Journal:  ASAIO J       Date:  2012 Jan-Feb       Impact factor: 2.872

4.  Albumin dialysis in cirrhosis with superimposed acute liver injury: a prospective, controlled study.

Authors:  Uwe Heemann; Ulrich Treichel; Jan Loock; Thomas Philipp; Guido Gerken; Massimo Malago; Sebastian Klammt; Matthias Loehr; Stephan Liebe; Steffen Mitzner; Reinhardt Schmidt; Jan Stange
Journal:  Hepatology       Date:  2002-10       Impact factor: 17.425

Review 5.  Acute liver failure in children.

Authors:  Joel B Cochran; Joseph D Losek
Journal:  Pediatr Emerg Care       Date:  2007-02       Impact factor: 1.454

6.  Treatment of refractory cholestatic pruritus after liver transplantation with albumin dialysis.

Authors:  Romuald Bellmann; Ivo W Graziadei; Clemens Feistritzer; Hubert Schwaighofer; Frans Stellaard; Ekkehard Sturm; Christian J Wiedermann; Michael Joannidis
Journal:  Liver Transpl       Date:  2004-01       Impact factor: 5.799

7.  Extracorporeal albumin dialysis: a procedure for prolonged relief of intractable pruritus in patients with primary biliary cirrhosis.

Authors:  Albert Parés; Laura Cisneros; Joan M Salmerón; Llorenç Caballería; Antoni Mas; Albert Torras; Juan Rodés
Journal:  Am J Gastroenterol       Date:  2004-06       Impact factor: 10.864

8.  Randomized controlled study of extracorporeal albumin dialysis for hepatic encephalopathy in advanced cirrhosis.

Authors:  Tarek I Hassanein; Flemming Tofteng; Robert S Brown; Brendan McGuire; Patrick Lynch; Ravindra Mehta; Fin S Larsen; Jeff Gornbein; Jan Stange; Andres T Blei
Journal:  Hepatology       Date:  2007-12       Impact factor: 17.425

9.  Hepatic and systemic haemodynamic changes after MARS in patients with acute on chronic liver failure.

Authors:  María-Vega Catalina; José Barrio; Fernando Anaya; Magdalena Salcedo; Diego Rincón; Gerardo Clemente; Rafael Bañares
Journal:  Liver Int       Date:  2003       Impact factor: 5.828

10.  Dialysis against a recycled albumin solution enables the removal of albumin-bound toxins.

Authors:  J Stange; W Ramlow; S Mitzner; R Schmidt; H Klinkmann
Journal:  Artif Organs       Date:  1993-09       Impact factor: 3.094

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.